Los Angeles, California -- As compliance concerns increasingly separate medical science liaisons (MSL) programs from commercial involvement, demonstrating the value of MSL programs will involve internal stakeholder support that may also include appropriate commercial support. This often involves appropriate and documented interactions between MSL teams and their sales and marketing colleagues.
"If you ask medical science liaisons who their stakeholders are, most MSLs will immediately talk about thought leaders in a therapeutic area," said Jane Chin, PhD, President of Medical Science Liaison Institute. "Internal stakeholders may not be at the forefront of MSLs' minds, and in many cases, MSLs may even resist interacting with commercially-
However, based on an annual survey of 18 field-based medical science liaison programs, internal stakeholder support is a critical component of MSLs' annual objectives, and therefore a critical component when formulating MSL program metrics.
QUANTIFYING AN INTANGIBLE: 2007 Medical Science Liaison Metrics Survey, available at http://www.MSLmetrics.com/
To learn more about this 7-chapter, 98-page report, visit http://www.MSLmetrics.com/


